BOW Stock Analysis: Bowhead Specialty Holdings | NYSE
Insurance - Property & Casualty | NYSE, USA | Market Cap: 1.035m USD | 12M Return: -6.5% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.02M
Qual. Beats: 3
Rev. Trend: 99.2%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 2.1 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Bowhead Specialty Holdings Inc. (NYSE: BOW) is a U.S.-focused commercial specialty property and casualty insurer that underwrites casualty, professional liability, crime, cyber, and healthcare-related coverage for niche client segments including construction, hospitality, financial institutions, and medical facilities. The specialty P&C market typically serves risks that standard admitted carriers are unwilling to underwrite, often because of complexity, size, or industry-specific exposures.
The company distributes its products through wholesale and retail partners and operates Baleen Specialty, a technology-enabled underwriting platform that targets small to mid-sized accounts placed in the non-admitted (E&S) market, where insurers are not bound by state-form filed rates and policy forms. Headquartered in New York and founded in 2020, Bowhead is a relatively young insurer that completed its IPO in 2024 and rebranded from Bowhead Holdings Inc. earlier that year.
- Specialty casualty premium growth outpaces industry average
- Combined ratio improvement drives underwriting profitability
- Higher interest rates boost investment income on insurance float
| Net Income: 58.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA -3.13 > 1.0 |
| NWC/Revenue: -33.15% < 20% (prev -29.78%; Δ -3.37% < -1%) |
| CFO/TA 0.14 > 3% & CFO 347.5m > Net Income 58.4m |
| Net Debt (-746.5m) to EBITDA (80.3m): -9.29 < 3 |
| Current Ratio: 0.90 > 1.5 & < 3 |
| Outstanding Shares: last quarter (33.3m) vs 12m ago -1.27% < -2% |
| Gross Margin: 34.41% > 18% (prev 33.83%; Δ 0.58% > 0.5%) |
| Asset Turnover: 27.58% > 50% (prev 26.11%; Δ 1.47% > 0%) |
| Interest Coverage Ratio: 15.90 > 6 (EBIT TTM 78.3m / Interest Expense TTM 4.93m) |
| A: -0.08 (Total Current Assets 1.66b - Total Current Liabilities 1.85b) / Total Assets 2.48b |
| B: 0.05 (Retained Earnings 132.7m / Total Assets 2.48b) |
| C: 0.04 (EBIT TTM 78.3m / Avg Total Assets 2.12b) |
| D: 0.23 (Book Value of Equity 459.2m / Total Liabilities 2.02b) |
| Altman-Z'' = 0.15 = B |
| DSRI: 1.14 (Receivables 530.6m/366.4m, Revenue 583.6m/457.7m) |
| GMI: 0.98 (GM 33.83% / 34.41%) |
| AQI: 1.08 (AQ_t 0.33 / AQ_t-1 0.30) |
| SGI: 1.28 (Revenue 583.6m / 457.7m) |
| TATA: -0.12 (NI 58.4m - CFO 347.5m) / TA 2.48b) |
| Beneish M = -2.70 (Cap -4..+1) = A |
As of July 10, 2026, the stock is trading at USD 32.30 with a total of 92,768 shares traded. Over the past week, the price has changed by +3.53%, over one month by +23.42%, over three months by +34.19% and over the past year by -6.49%.
Current recommended Stop Loss: 30.80 (which is 4.6% or 1.4 ATR below the current price).
Bowhead Specialty Holdings has received a consensus analysts rating of 3.60. Therefore, it is recommended to hold BOW.
- StrongBuy: 0
- Buy: 3
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 31.4 | -2.7% |
P/E Trailing = 18.2254
P/E Forward = 14.9925
P/S = 1.7712
P/B = 2.2514
Revenue TTM = 583.6m USD
EBIT TTM = 78.3m USD
EBITDA TTM = 80.3m USD
Long Term Debt = 146.5m USD (from longTermDebt, last quarter)
Short Term Debt = 1.42m USD (from shortTermDebt, last fiscal year)
Debt = 146.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -746.5m USD (calculated: Debt 146.5m - CCE 893.0m)
Enterprise Value = 288.9m USD (1.04b + Debt 146.5m - CCE 893.0m)
Interest Coverage Ratio = 15.90 (Ebit TTM 78.3m / Interest Expense TTM 4.93m)
EV/FCF = 0.84x (Enterprise Value 288.9m / FCF TTM 341.9m)
FCF Yield = 118.4% (FCF TTM 341.9m / Enterprise Value 288.9m)
FCF Margin = 58.58% (FCF TTM 341.9m / Revenue TTM 583.6m)
Net Margin = 10.00% (Net Income TTM 58.4m / Revenue TTM 583.6m)
Gross Margin = 34.41% ((Revenue TTM 583.6m - Cost of Revenue TTM 382.8m) / Revenue TTM)
Gross Margin QoQ = 40.91% (prev 31.27%)
Tobins Q-Ratio = 0.12 (Enterprise Value 288.9m / Total Assets 2.48b)
Interest Expense / Debt = 3.36% (Interest Expense 4.93m / Debt 146.5m)
Taxrate = 20.47% (15.0m / 73.4m)
NOPAT = 62.3m (EBIT 78.3m * (1 - 20.47%))
Current Ratio = 0.90 (Total Current Assets 1.66b / Total Current Liabilities 1.85b)
Debt / Equity = 0.32 (Debt 146.5m / totalStockholderEquity, last quarter 459.2m)
Debt / EBITDA = -9.29 (Net Debt -746.5m / EBITDA 80.3m)
Debt / FCF = -2.18 (Net Debt -746.5m / FCF TTM 341.9m)
Total Stockholder Equity = 436.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.76% (Net Income 58.4m / Total Assets 2.48b)
RoE = 13.37% (Net Income TTM 58.4m / Total Stockholder Equity 436.5m)
RoCE = 13.44% (EBIT 78.3m / Capital Employed (Equity 436.5m + L.T.Debt 146.5m))
RoIC = 10.42% (NOPAT 62.3m / Invested Capital 597.9m)
WACC = 5.60% (E(1.04b)/V(1.18b) * Re(6.01%) + D(146.5m)/V(1.18b) * Rd(3.36%) * (1-Tc(0.20)))
Discount Rate = 6.01% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 47.74 | Cagr: 2.44%
[DCF] Terminal Value 77.97% ; FCFF base≈323.7m ; Y1≈371.1m ; Y5≈546.2m
[DCF] Fair Price = 273.0 (EV 8.22b - Net Debt -746.5m = Equity 8.97b / Shares 32.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 2.78 | # QB: 3
Revenue Correlation: 99.19 | Revenue CAGR: 39.50% | SUE: 0.13 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.47 | Chg30d=+0.00% | Revisions=+30% | Analysts=7
EPS next Quarter (2026-09-30): EPS=0.51 | Chg30d=+0.00% | Revisions=+0% | Analysts=7
EPS current Year (2026-12-31): EPS=2.00 | Chg30d=+0.00% | Revisions=+44% | GrowthEPS=+21.2% | GrowthRev=+23.5%
EPS next Year (2027-12-31): EPS=2.42 | Chg30d=+0.00% | Revisions=+22% | GrowthEPS=+21.0% | GrowthRev=+18.7%
[Analyst] Revisions Ratio: +32% (up=17, down=8)